naropin

Generic: ropivacaine hydrochloride

Labeler: henry schein, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name naropin
Generic Name ropivacaine hydrochloride
Labeler henry schein, inc.
Dosage Form INJECTION, SOLUTION
Routes
EPIDURAL INFILTRATION PERINEURAL
Active Ingredients

ropivacaine hydrochloride 5 mg/mL

Manufacturer
Henry Schein, Inc.

Identifiers & Regulatory

Product NDC 0404-9924
Product ID 0404-9924_47641628-e7ea-4e6b-a214-4a834fcc56be
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020533
Listing Expiration 2026-12-31
Marketing Start 2022-01-13

Pharmacologic Class

Classes
amide local anesthetic [epc] amides [cs] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04049924
Hyphenated Format 0404-9924

Supplemental Identifiers

RxCUI
1734475 1734476
UNII
V910P86109

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naropin (source: ndc)
Generic Name ropivacaine hydrochloride (source: ndc)
Application Number NDA020533 (source: ndc)
Routes
EPIDURAL INFILTRATION PERINEURAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9924-30) / 30 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

ropivacaine hydrochloride (5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "spl_id": "47641628-e7ea-4e6b-a214-4a834fcc56be", "openfda": {"unii": ["V910P86109"], "rxcui": ["1734475", "1734476"], "spl_set_id": ["6a2f1f6d-026f-4f39-aee0-5b75b8eb5c02"], "manufacturer_name": ["Henry Schein, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 BAG (0404-9924-30)  / 30 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0404-9924-30", "marketing_start_date": "20220113"}], "brand_name": "NAROPIN", "product_id": "0404-9924_47641628-e7ea-4e6b-a214-4a834fcc56be", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "0404-9924", "generic_name": "ropivacaine hydrochloride", "labeler_name": "Henry Schein, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NAROPIN", "active_ingredients": [{"name": "ROPIVACAINE HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "NDA020533", "marketing_category": "NDA", "marketing_start_date": "20220113", "listing_expiration_date": "20261231"}